Patrick S. Stayton
Corporate Officer/Principal chez University of Washington
Profil
Dr. Patrick Stayton is Co-Founder at PhaseRx, Inc. and a Professor at University of Washington.
Postes actifs de Patrick S. Stayton
| Sociétés | Poste | Début |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 21/08/2009 |
Anciens postes connus de Patrick S. Stayton
| Sociétés | Poste | Fin |
|---|---|---|
Nexgenia, Inc.
 Nexgenia, Inc. Medical SpecialtiesHealth Technology Nexgenia, Inc. develops molecule-specific selection reagents. Its technology include polymer-protein conjugates and magnetic nanoparticles. The company was founded by James Lai and Thomas Schulte in February 2011 and is headquartered in Seattle, WA. | Fondateur | - |
| PHASERX, INC. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHASERX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nexgenia, Inc.
Nexgenia, Inc. Medical SpecialtiesHealth Technology Nexgenia, Inc. develops molecule-specific selection reagents. Its technology include polymer-protein conjugates and magnetic nanoparticles. The company was founded by James Lai and Thomas Schulte in February 2011 and is headquartered in Seattle, WA. | Health Technology |
